Telmisartan is primarily used in dogs to reduce proteinuria (excess protein in the urine) caused by kidney disease, and as a treatment for high blood pressure. It belongs to a class of drugs called angiotensin receptor blockers, or ARBs, and it works by blocking a hormone that constricts blood vessels and puts pressure on the kidneys. While it’s more widely licensed for cats in some countries, veterinarians increasingly prescribe it off-label for dogs with chronic kidney disease and related complications.
Proteinuria and Kidney Disease
The most common reason a vet prescribes telmisartan for a dog is proteinuria, a condition where damaged kidneys leak protein into the urine. Proteinuria is both a sign of kidney disease and a driver of further kidney damage. Left unchecked, the protein passing through the kidneys causes ongoing inflammation and scarring, accelerating the decline in kidney function. Telmisartan helps by reducing the pressure inside the kidney’s filtering units, which slows the protein leak and protects the remaining healthy tissue.
In a randomized clinical trial comparing telmisartan to enalapril (a commonly used ACE inhibitor) in 39 dogs with chronic kidney disease, telmisartan reduced urinary protein levels by 65% at day 30, compared to 35% with enalapril. Dogs on telmisartan also reached a meaningful reduction faster: a median of 30 days versus 90 days for enalapril. By day 30, dogs on telmisartan were nearly seven times more likely to have achieved at least a 50% drop in protein levels. Telmisartan maintained its advantage through 60 and 90 days of follow-up, leading researchers to suggest it may be a suitable first-line therapy for dogs with renal proteinuria.
High Blood Pressure
Telmisartan is also used to manage systemic hypertension in dogs, particularly when high blood pressure accompanies kidney disease. The American College of Veterinary Internal Medicine (ACVIM) lists telmisartan at 1.0 mg/kg once daily as an alternative method for blocking the renin-angiotensin system in hypertensive dogs. Uncontrolled high blood pressure can damage the eyes, brain, heart, and kidneys, so bringing it under control is a key part of managing kidney disease overall.
Most of the published clinical trial data on telmisartan and blood pressure comes from cats, where it has been more extensively studied and is formally licensed in Europe. In dogs, it is used based on its known pharmacology, emerging clinical evidence, and extrapolation from the feline data. Your vet may choose telmisartan over older blood pressure medications if your dog also has significant proteinuria, since it addresses both problems simultaneously.
How Telmisartan Works
Your dog’s body has a hormone system called the renin-angiotensin-aldosterone system (RAAS) that regulates blood pressure and fluid balance. When this system is overactive, it produces a hormone called angiotensin II, which tightens blood vessels and increases pressure inside the kidneys. Telmisartan blocks the receptor where angiotensin II attaches, preventing it from having its effect.
This makes telmisartan different from ACE inhibitors like enalapril or benazepril, which work one step earlier by reducing the production of angiotensin II. The problem with ACE inhibitors is that the body can produce angiotensin II through alternative pathways, bypassing the block. Because telmisartan acts directly at the receptor, it blocks angiotensin II regardless of how it was produced, which may explain its stronger effect on proteinuria in head-to-head comparisons.
How It’s Given
Telmisartan is typically given once a day, with or without food. It’s available as tablets (in 20 mg, 40 mg, and 80 mg sizes) and as an oral liquid solution. The liquid form, marketed under the brand name Semintra, can be easier to dose precisely in smaller dogs or those that resist swallowing pills. Micardis is the human brand name your vet may reference. The standard dose used in clinical studies for dogs is 1.0 mg per kilogram of body weight, given once daily, though your vet may adjust this based on your dog’s response and bloodwork.
Side Effects and Safety
Telmisartan is generally well tolerated in dogs. In a retrospective study published in the Journal of Veterinary Internal Medicine, the most common side effects were mild, self-limiting gastrointestinal issues: loss of appetite and diarrhea. These resolved on their own in the affected dogs.
The more serious concern is a potential decline in kidney function. In the same study, two dogs developed a significant rise in creatinine (a waste product that accumulates when the kidneys aren’t filtering well), which required stopping the medication. This happens because telmisartan lowers the pressure inside the kidney’s filters. For most dogs, that’s beneficial, but in some cases, particularly when the kidneys are already severely compromised, it can reduce blood flow to the kidneys enough to worsen function.
On the reassuring side, the study found no significant changes in kidney values, potassium levels, or blood pressure across all follow-up visits for the group as a whole. No dog developed dangerously high potassium, which is a theoretical risk with drugs that block the RAAS. Still, your vet will want to recheck bloodwork within the first few weeks of starting treatment to catch any early problems, and periodically after that.
Telmisartan vs. ACE Inhibitors
For years, ACE inhibitors like enalapril and benazepril were the standard choice for managing proteinuria in dogs with kidney disease. Telmisartan has emerged as a potentially stronger option. The clinical trial data showing a 65% reduction in protein levels versus 35% with enalapril is notable, as is the faster onset of action. Dogs reached meaningful improvement in one month on telmisartan compared to three months on enalapril.
Some vets still start with an ACE inhibitor, particularly if they have long experience with it and the dog’s proteinuria is mild. Others now reach for telmisartan first, especially in dogs with more significant protein loss. In some cases, the two drugs are combined, though this requires closer monitoring since both affect the same hormone system and together can increase the risk of low blood pressure or rising kidney values. The decision depends on the severity of your dog’s condition and how they respond to initial treatment.
What to Expect During Treatment
Telmisartan is not a cure for kidney disease. It’s a management tool that slows progression by protecting the kidneys from the damage caused by excess protein leakage and high blood pressure. Most dogs stay on it long-term, often for the rest of their lives. The goal is to keep urinary protein levels as low as possible and maintain stable kidney function over time.
After starting the medication, your vet will likely schedule a recheck within two to four weeks. This visit typically includes bloodwork to measure kidney values and potassium, a urine test to see whether protein levels are dropping, and a blood pressure reading. If everything looks stable, follow-up intervals may stretch to every few months. If your dog stops eating, develops diarrhea, or seems unusually lethargic after starting telmisartan, contact your vet, as these could signal a side effect that needs attention.